Wednesday, February 10, 2010, 7:45am EST - Canadian Markets open in 1 hour and 45 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Alexion Pharmaceuticals, Inc. (ALXN)

 On Feb 9: 46.91 USD   0.00 (0.00%)  
MORE ON ALXN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Alexion Pharmaceuticals, Inc. (NasdaqNM:ALXN) Delayed quote dataEdit
Last Trade: 46.91 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 46.91
Open: N/A
Bid: 0.01 x 100
Ask: 2,000.00 x 100
1y Target Est: 55.11
Day's Range: N/A - N/A
52wk Range: 30.78 - 49.57
Volume: 0
Avg Vol (3m): 508,490
Market Cap: 4.15B
P/E (ttm): 57.77
EPS (ttm): 0.81
Div & Yield: N/A (N/A%)
Alexion Pharmaceuticals, Inc. (ALXN)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add ALXN to Portfolio   Download Data

HEADLINES
• ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fina
EDGAR Online (Thu, Jan 28)
• Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2009 Results on February 11, 2010
Business Wire (Thu, Jan 28)
• Capital Requirements Increase In Diagnostic And Lab Equipment Sector: Northland Securities Industry Expert Picks The Stock Winners And Losers
Wall Street Transcript (Wed, Jan 27)
• Personalized Medicine Creates New Opportunities For Diagnostics Stocks
Wall Street Transcript (Sun, Jan 24)
• Study: orphan drug applications doubled in 200s
AP (Wed, Jan 20)
• Coverage initiated on Alexion Pharma by Oppenheimer
Briefing.com (Wed, Jan 20)
• PhRMA adds 7 biotech companies to its membership
AP (Fri, Jan 8)
• Alexion to Present at the 28th Annual JP Morgan Healthcare Conference
Business Wire (Wed, Jan 6)
• [$$] How to Bet on Health and Wealth
at Barrons.com (Tue, Jan 5)
• Rigel Pharma Gives Up Gains
at Barrons.com (Mon, Dec 21)
• How to Profit From the "New Normal"
at Motley Fool (Tue, Dec 8)
More Headlines for ALXN...
ANALYST
EPS Est (next year) (Dec-09) : 0.89
EPS Est (in 2 years) (Dec-10) : 1.21
Avg Rec (current)*: 1.8
PEG Ratio: 1.59
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and delivers drug therapies for patients with various medical conditions. It primarily engages in the discovery, development, and commercialization of biologic therapeutic produc...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices